BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DSS TIME LN STATUS PGR STATUS DMFS TIME HISTOLOGICAL GRADE SIZE MM TREATMENT TYPE DFS TIME DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER CHARACTERISTICS HISTOLOGY YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS HER2 STATUS PATIENT AGE
GSM1100175 NA LN- NA 9.419 G1 21 none 9.42 not specified not specified endocrine? (0=no, 1=yes): 0 NA not specified NA ER+ NA 43
GSM1100174 NA LN- NA 10.614 G2 23 none 10.61 1 not specified endocrine? (0=no, 1=yes): 0 NA not specified NA ER- NA 37
GSM1100173 NA LN- NA 7.151 NA 10 none 7.15 1 1 endocrine? (0=no, 1=yes): 0 NA not specified NA ER- NA 67
GSM1100172 1.66027397260274 LN- PgR- 1.66 G3 29 CMFx6 NA NA not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- He- 50
GSM110017 4.50958904109589 LN- PgR- 4.51 G2 20 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 72
GSM1100170 3.92602739726027 LN- PgR+ 3.93 G1 30 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 56
GSM1100169 4.95890410958904 LN- PgR- 4.96 G3 27 CMFx6; Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- 46
GSM1100168 4.56164383561644 LN- PgR+ 4.56 G2 30 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 45
GSM1100167 5.00821917808219 LN- PgR- 5.01 G3 60 CMFx6 NA NA not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- He+ 48
GSM1100166 4.64383561643836 LN- PgR+ 4.64 G2 20 CMFx6 NA NA not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- 45
GSM1100165 5.13424657534247 LN- PgR- 5.13 G2 20 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 70
GSM1100164 6.25753424657534 LN- PgR- 6.26 G3 45 ACx4 NA NA not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER- NA 59
GSM1100163 5.56712328767123 LN- PgR- 5.57 G3 14 CMFx6; Arimidex/Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- 61
GSM1100162 5.10958904109589 LN- PgR+ 5.11 G3 20 ACx4; Arimidex/Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 60
GSM110016 5.52328767123288 LN- PgR+ 5.52 G3 19 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 53
GSM1100160 6.69315068493151 LN- PgR+ 6.69 G2 14 CMFx6 NA NA not specified endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- 42
GSM1100159 6.18630136986301 LN- PgR- 6.19 NA 38 NA NA NA not specified endocrine? (0=no, 1=yes): NA NA NA not specified ER- He- 73
GSM1100158 2.57260273972603 LN- NA 2.57 G3 32 CMFx6; Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified NA NA 46
GSM1100157 3.11506849315069 LN- PgR- 3.12 G1 20 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 57
GSM1100156 5.93698630136986 LN- PgR+ 5.94 G1 27 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 66
GSM1100155 6.12876712328767 LN- PgR+ 6.13 G3 27 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 62
GSM1100154 6.61369863013699 LN- PgR- 6.61 G3 40 ACx6; Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- 67
GSM1100153 6.65205479452055 LN- PgR- 6.65 G2 35 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 70
GSM1100152 6.17534246575342 LN- PgR+ 6.18 G2 15 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 77
GSM110015 6.01917808219178 LN- PgR- 6.02 G2 20 ACx4; Tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He+ 52
GSM1100150 7.57260273972603 LN- PgR- 7.57 G2 20 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 81
GSM1100149 7.30684931506849 LN- PgR+ 7.31 G3 18 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 55
GSM1100148 7.85479452054795 LN- NA 7.85 G2 12 Tamoxifen+Zoledronic acid NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 48
GSM1100147 7.82191780821918 LN- PgR- 7.82 G2 10 tamoxifen NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- 54
GSM1100146 5.16438356164384 LN- PgR+ 3.30 G3 37 Arimidex/Tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He+ 72
GSM1100145 6.75068493150685 LN- PgR+ 3.65 G3 40 CMFx2; Tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 60
GSM1100144 8.02191780821918 LN- PgR- 6.15 G1 55 ACx4 NA NA 1 endocrine? (0=no, 1=yes): 0 NA 1 not specified ER+ He- 54
GSM1100143 7.07945205479452 LN- PgR- 2.42 G2 13 Tamoxifen+Zoledronic acid NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 not specified ER- He- 36
GSM1100142 2.18904109589041 LN- PgR- 2.18 G1 10 Tamoxifen+Zoledronic acid NA NA not specified endocrine? (0=no, 1=yes): 1 NA 1 not specified ER+ He- 46
GSM110014 0.991780821917808 LN- PgR+ 0.76 G3 35 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ 70
GSM1100140 4.62191780821918 LN- PgR- 3.80 G3 34 ACx3/CMFx1 NA NA 1 endocrine? (0=no, 1=yes): 0 NA 1 1 ER- He- 73
GSM1100139 4.92876712328767 LN- PgR+ 2.21 G3 46 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- 63
GSM1100138 2.75342465753425 LN- PgR- 1.35 G3 32 ECx4; Tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- 38
GSM1100137 5.03561643835616 LN- PgR+ 0.25 NA 85 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ 57
GSM1100136 6.17260273972603 LN- PgR+ 4.51 G3 17 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He- 68
GSM1100135 4.19452054794521 LN- PgR- 4.18 G3 21 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER- He- 66
GSM1100134 3.07945205479452 LN- PgR- 0.65 G3 25 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER- He+ 59
GSM1100133 2.12602739726027 LN- PgR+ 1.39 G3 28 CMFx6; Tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ 47
GSM1100132 3.44931506849315 LN- NA 3.05 G2 30 tamoxifen NA NA 1 endocrine? (0=no, 1=yes): 1 NA 1 1 ER+ He+ 63
GSM110013 4.33 LN+ PgR+ 4.33 G3 35 Tam+CMFx6 cycles 4.33 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ NA 53
GSM1100130 4.83 LN+ PgR+ 4.83 G1 60 NA 4.83 not specified not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He- 59
GSM1100129 4.38 LN- PgR+ 4.38 G3 20 tamoxifen 4.38 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 62
GSM1100128 2.67 LN+ PgR+ 2.67 G1 24 Tam+ACx4 cycles 2.67 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 43
GSM1100127 4.67 LN- NA 4.67 G1 25 none 4.67 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma and papillary carcinoma not specified not specified NA NA 55
GSM1100126 0.83 LN- PgR+ 0.83 G3 28 tamoxifen 0.83 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 84
GSM1100125 2.00 LN+ PgR+ 2.00 G3 40 Tam+AC 2.00 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 38
GSM1100124 4.92 LN+ PgR- 4.92 G3 25 tamoxifen 4.92 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 67
GSM1100123 5.17 LN- PgR+ 5.17 G1 20 tamoxifen 5.17 not specified not specified endocrine? (0=no, 1=yes): 1 invasive lobular carcinoma 1 not specified ER+ He- 52
GSM1100122 5.75 LN+ PgR+ 3.83 G3 16 Tam+ACx4 cycles 3.83 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He+ 50
GSM110012 5.21 LN- PgR+ 5.21 G3 50 tamoxifen 5.21 not specified not specified endocrine? (0=no, 1=yes): 1 medullary carcinoma 1 not specified ER+ He+ 64
GSM1100120 4.54 LN+ PgR+ 4.54 G3 30 CAF 4.54 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 47
GSM1100119 5.58 LN- PgR+ 5.58 G3 38 Tam+ACx4 cycles 5.58 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 38
GSM1100118 5.92 LN+ PgR+ 5.92 G3 51 Tam+ACx4 cycles 5.92 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 58
GSM1100117 5.88 LN- PgR- 5.88 G3 21 ACx4 cycles 5.88 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 47
GSM1100116 5.79 LN- PgR- 5.79 G3 18 Tam+CMFx6 cycles 5.79 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 51
GSM1100115 5.83 LN- PgR- 5.83 G3 35 ACx4 cycles 5.83 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 48
GSM1100114 5.83 LN- PgR- 5.83 G3 25 ACx4 cycles 5.83 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 46
GSM1100113 5.58 LN- PgR- 1.33 G3 27 ACx4 cycles 1.92 1 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 51
GSM1100112 6.17 LN- PgR+ 6.17 G3 25 Tam+CMFx6 cycles 6.17 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 36
GSM1100 5.83 LN+ PgR- 5.83 G3 15 CAFx6 cycles 5.83 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 61
GSM1100110 5.71 LN- PgR- 5.71 G3 32 ACx4 cycles 5.71 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 48
GSM1100109 5.88 LN+ PgR- 5.88 G3 25 CMF 5.88 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 61
GSM1100108 6.50 LN- PgR- 1.17 G3 20 none 1.17 not specified not specified endocrine? (0=no, 1=yes): 0 medullary carcinoma not specified not specified ER- He- 42
GSM1100107 4.33 LN- PgR+ 3.50 G1 40 tamoxifen 3.50 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 77
GSM1100106 NA LN- PgR+ NA G1 40 tamoxifen NA NA NA endocrine? (0=no, 1=yes): 1 papillary carcinoma 1 NA ER+ He- 81
GSM1100105 4.00 LN- PgR- 4.00 G3 23 NA 4.00 not specified not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER- He+ 42
GSM1100104 2.88 LN- PgR- 2.29 G3 36 Tam+ACx4 cycles 2.29 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 38
GSM1100103 1.46 LN+ PgR- 0.79 G3 30 ACx4 cycles 0.79 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 51
GSM1100102 5.79 LN- PgR+ 5.58 G1 15 Tam+CMFx6 cycles 5.58 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 60
GSM110010 6.29 LN+ PgR+ 6.29 G3 45 Tam+ACx4 cycles 6.29 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 52
GSM1100100 0.75 LN- PgR- 0.75 G3 35 ACx4 cycles 0.75 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 48
GSM1100099 4.25 LN- PgR- 4.17 G3 22 AC 4.17 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 42
GSM1100098 5.08 LN+ PgR- 5.08 G3 30 ACx4 cycles 5.08 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 48
GSM1100097 4.38 LN+ PgR+ 4.38 G3 35 ACx8 cycles; taxol 4.38 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ 34
GSM1100096 3.04 LN+ PgR+ 2.21 G1 80 CAFx6 cycles 2.21 1 1 endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 1 ER+ He- 29
GSM1100095 4.38 LN+ PgR+ 3.13 G1 21 tamoxifen 3.13 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 86
GSM1100094 1.38 LN+ PgR- 1.29 G3 35 CAF 1.29 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 1 ER- He+ 54
GSM1100093 0.38 LN+ PgR- 0.13 G3 22 NA 0.13 1 1 endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA 1 ER- He+ 46
GSM1100092 5.54 LN- PgR- 5.54 G3 40 ACx4 cycles 5.54 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 41
GSM110009 1.96 LN+ PgR+ 1.96 G3 40 tamoxifen 1.96 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 80
GSM1100090 4.83 LN+ PgR- 4.83 G3 20 CAF 4.83 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 45
GSM1100089 5.08 LN- PgR- 5.08 G3 30 ACx4 cycles 5.08 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 64
GSM1100088 1.00 LN+ PgR- 0.88 G3 35 none 0.88 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ 62
GSM1100087 2.08 LN+ PgR+ 0.00 G3 25 Arimidex+CMFx2 cycles 0.00 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ 62
GSM1100086 1.96 LN+ PgR+ 1.96 G3 30 CAF 1.96 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ 58
GSM1100085 5.29 LN+ PgR+ 5.25 G3 25 AC 5.25 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ 45
GSM1100084 4.63 LN+ PgR- 3.96 G3 20 ACx4 cycles 3.96 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 1 ER- He+ 54
GSM1100083 4.00 LN+ PgR- 4.00 G3 50 ACx4 cycles 4.00 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- NA 44
GSM1100082 2.25 LN+ PgR- 2.04 G3 30 tamoxifen 2.04 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ 74
GSM110008 4.33 LN+ PgR- 4.00 G3 35 ACx4 cycles 4.00 not specified not specified endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 not specified ER- He+ 52
GSM1100080 5.00 LN- PgR- 1.00 G3 60 ACx4 cycles 1.00 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 55
GSM1100079 0.13 LN- PgR+ 0.13 G1 38 tamoxifen NA not specified not specified endocrine? (0=no, 1=yes): 1 mucinous carcinoma 1 not specified ER+ He- 66
GSM1100078 4.88 LN+ PgR+ 4.88 G3 32 CAF 4.88 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 47
GSM1100077 4.46 LN- PgR+ 4.46 G3 20 tamoxifen 4.46 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 55
GSM1100076 5.46 LN- PgR+ 5.46 G1 15 tamoxifen;goserelin 5.46 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 45
GSM1100075 5.46 LN- PgR- 1.54 G3 40 ACx4 cycles 1.54 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 34
GSM1100074 5.00 LN- PgR+ 5.00 G2 35 ACx4 cycles 5.00 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 47
GSM1100073 5.33 LN- PgR+ 5.33 G2 15 tamoxifen 5.33 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 49
GSM1100072 5.58 LN- PgR+ 5.58 G2 12 tamoxifen 5.58 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 64
GSM110007 0.08 LN- PgR+ NA G2 17 NA NA NA NA endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He+ 66
GSM1100070 4.50 LN+ PgR+ 4.00 G2 40 NA 4.00 not specified not specified endocrine? (0=no, 1=yes): NA invasive ductal and lobular carcinoma NA not specified ER- He- 46
GSM1100069 4.92 LN+ PgR+ 4.83 G2 20 tamoxifen 4.83 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 73
GSM1100068 4.88 LN- PgR+ 4.88 G2 15 Tam+CMFx6 cycles 4.88 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 46
GSM1100067 4.50 LN+ PgR- 4.50 G2 30 NA 4.50 not specified not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He- 42
GSM1100066 1.75 LN+ PgR- 1.67 G2 60 Tam+CAFx2 cycles 1.67 1 1 endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 1 ER+ He+ 46
GSM1100065 0.42 LN+ PgR+ 0.42 G2 24 none 0.42 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER+ He+ 44
GSM1100064 4.92 LN+ PgR+ 4.92 G2 19 tamoxifen 4.92 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 55
GSM1100063 4.75 LN- PgR+ 4.75 G2 21 tamoxifen 4.75 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 57
GSM1100062 5.17 LN+ PgR+ 5.17 G2 23 CAF 5.17 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 40
GSM110006 4.67 LN- PgR+ 4.67 G2 35 CMF 4.67 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 44
GSM1100060 5.67 LN+ PgR+ 5.67 G2 30 CAF 5.67 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He+ 46
GSM1100059 4.67 LN- PgR+ 4.67 G2 40 Tam+ACx4 cycles 4.67 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He- 35
GSM1100058 4.58 LN- PgR+ 0.67 G2 15 none 1.25 1 not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER+ He- 55
GSM1100057 2.83 LN- PgR- 2.83 G2 25 none 2.83 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ 67
GSM1100056 5.42 LN+ PgR+ 0.67 G2 40 tamoxifen 0.92 1 not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER- He+ 75
GSM1100055 3.08 LN- PgR- 0.04 G2 15 anastrozole;taxol 0.04 1 1 endocrine? (0=no, 1=yes): 0 invasive lobular carcinoma 1 1 ER+ He- 48
GSM1100054 5.25 LN+ PgR+ 5.25 G2 23 Tam+CAFx6 cycles 5.25 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 49
GSM1100053 5.00 LN+ PgR+ 5.00 G2 25 CAF 5.00 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 69
GSM1100052 NA LN+ PgR- NA G2 25 Tam+ACx8;taxol NA NA NA endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 NA ER+ He+ 51
GSM110005 6.33 LN- PgR+ 6.33 G2 20 Tam+CMFx6 cycles 6.33 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 60
GSM1100050 5.58 LN- PgR- 5.58 G2 35 tamoxifen 5.58 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 77
GSM1100049 5.92 LN+ PgR+ 5.75 G2 22 CMF 5.75 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 53
GSM1100048 5.83 LN+ PgR+ 5.83 G2 25 CAF 5.83 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He- 50
GSM1100047 5.79 LN- PgR+ 5.79 G2 18 CMF 5.79 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER+ He- 52
GSM1100046 6.00 LN- PgR- 6.00 G2 18 tamoxifen 6.00 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 53
GSM1100045 4.08 LN- PgR- 4.04 G2 15 none 4.04 not specified not specified endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma not specified not specified ER- He+ 46
GSM1100044 5.63 LN- PgR+ 5.63 G2 20 NA 5.63 not specified not specified endocrine? (0=no, 1=yes): NA invasive ductal carcinoma NA not specified ER+ He+ 48
GSM1100043 2.25 LN+ PgR- 2.00 G2 60 ACx4 cycles 2.00 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 54
GSM1100042 6.25 LN- PgR- 6.25 G2 25 tamoxifen 6.25 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 69
GSM110004 2.63 LN- PgR+ 2.63 G2 25 Tam+CMFx6 cycles 2.63 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He+ 40
GSM1100040 6.04 LN- PgR+ 5.88 G2 35 tamoxifen 5.88 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 69
GSM1100039 4.29 LN- PgR+ 4.29 G2 30 tamoxifen 4.29 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 69
GSM1100038 1.13 LN+ PgR- 1.13 G2 30 ACx4 cycles 1.13 1 1 endocrine? (0=no, 1=yes): 0 invasive ductal carcinoma 1 not specified ER- He+ 62
GSM1100037 6.17 LN- PgR+ 6.17 G2 20 Tam+ACx4 cycles 6.17 not specified not specified endocrine? (0=no, 1=yes): 1 invasive ductal carcinoma 1 not specified ER+ He- 41

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use